[Federal Register Volume 63, Number 165 (Wednesday, August 26, 1998)]
[Proposed Rules]
[Page 45427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-22813]



[[Page 45427]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 101

[Docket No. 98N-0044]
RIN 0910-AA59


Regulations on Statements Made for Dietary Supplements Concerning 
the Effect of the Product on the Structure or Function of the Body; 
Extension of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is extending to 
September 28, 1998, the comment period for the proposed rule that 
appeared in the  Federal Register of April 29, 1998 (63 FR 23624). The 
document proposed regulations defining the types of statements that can 
be made concerning the effect of a dietary supplement on the structure 
or function of the body. Interested persons were given until August 27, 
1998, to comment on the proposed rule. This action is being taken in 
response to requests for an extension of the comment period.
DATES: Written comments by September 28, 1998.

ADDRESSES: Submit written comments to the Dockets Management Branch 
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Jeanne Latham, Center for Food Safety 
and Applied Nutrition (HFS-456), Food and Drug Administration, 200 C 
St. SW., Washington, DC 20204, 202-205-4697.

SUPPLEMENTARY INFORMATION: In the Federal Register of April 29, 1998 
(63 FR 23624), FDA issued a proposed rule defining the types of 
statements that can be made concerning the effect of a dietary 
supplement on the structure or function of the body.
    Interested persons were given until August 27, 1998, to comment on 
the proposal. FDA has received several requests for an extension of the 
comment period. After evaluating these requests, the agency has decided 
to extend the comment period on the proposed rule until September 28, 
1998.
    To be considered, written comments regarding the proposed rule must 
be received by September 28, 1998, by the Dockets Management Branch 
(address above). Two copies of any comments are to be submitted, except 
that individuals may submit one copy. Comments are to be identified 
with Docket No. 98N-0044. Received comments may be seen in the Dockets 
Management Branch between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: August 20, 1998.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 98-22813 Filed 8-25-98; 8:45 am]
BILLING CODE 4160-01-F